plaque psoriasis
Phase 2b Trial: TAK-279 Improves Skin Clearance for Moderate to Severe Plaque Psoriasis
Results from a phase 2b trial indicate that the investigational drug TAK-279 (Takeda) significantly improved ...
MARCH 20, 2023
FDA Approves First Steroid-Free Cream for Plaque Psoriasis
Vtama is an aryl hydrocarbon receptor agonist approved for adults with plaque psoriasis.
MAY 24, 2022
Cimzia Receives New Indication for Moderate to Severe Plaque Psoriasis
The FDA approved a new indication for Cimzia to treat moderate to severe plaque psoriasis in adults.
MAY 30, 2018
Load more